oral glp-1 drugs in development Drug Trends: Market & Competition GLP-1 receptor agonists and next-generation

January 2026 The Cost of Omission: How Anthems Lack of Required Documentation to Manage Drug Availability Sparked a Class Action Over Zepbound Coverage Introduction In September 2025, a class action lawsuit was filed in the Southern District of Indiana, Newkirk v

They bind to GLP-1 receptors and activate them, providing the same benefits as the natural hormone but with a longer duration of action

Medications such as GLP-1 agonists or dual GIP/GLP-1 therapies can reduce liver volume, improve blood sugar, lower visceral fat burden, and stabilize metabolic fluctuations

No significant effect of monosomy for distal 21q22.3 on the Down syndrome phenotype in "mirror" duplications of chromosome 21